Pro Medicus Limited (ASX:PME)
Australia · Delayed Price · Currency is AUD 291.08
+4.07 (1.42%)
Oct 15, 2025, 3:48 PM AEST
Pro Medicus Market Cap
Pro Medicus has a market cap or net worth of 30.00 billion as of October 14, 2025. Its market cap has increased by 60.16% in one year.
Market Cap
30.00B
Enterprise Value
29.79B
Revenue
212.98M
Ranking
n/a
PE Ratio
260.68
Stock Price
291.08
Market Cap Chart
Since October 10, 2000, Pro Medicus's market cap has increased from 142.00M to 30.00B, an increase of 21,023.70%. That is a compound annual growth rate of 23.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 30.00B | 14.76% |
| Dec 31, 2024 | 26.14B | 161.11% |
| Dec 29, 2023 | 10.01B | 73.45% |
| Dec 30, 2022 | 5.77B | -11.46% |
| Dec 31, 2021 | 6.52B | 83.09% |
| Dec 31, 2020 | 3.56B | 53.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 101.12B |
| Cochlear | 18.15B |
| Sonic Healthcare | 10.40B |
| Ramsay Health Care | 7.34B |
| Telix Pharmaceuticals | 5.11B |
| Ansell | 4.73B |
| Mesoblast | 3.70B |
| Neuren Pharmaceuticals | 2.70B |